The North American region is observing rising investments in the field of drug discovery & development. Moreover, the need for advanced therapies due to the rising rate of chronic diseases such as cancer has contributed to the growth of the gene expression analysis market. Browse 436 market data Tables and 54 Figures spread through 369 […]
prominent players in the X-ray detectors market are Varex Imaging Corporation (US), Thales Group( France), Canon( Japan), Fujifilm Corporation (Japan), Agfa-Gevaert Group (Belgium) and Teledyne Technologies(US), and among others. The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall x-ray detectors market and the […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hodgkin’s Lymphoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Hodgkin’s Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Hodgkin’s Lymphoma Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]
Asthma Clinical Trials Asthma companies are Mabpharm Limited, GlaxoSmithKline, Immunotek SL, AB Science, AstraZeneca, Inmunotek, Sterna Biologics, Verona Pharma, MediciNova, Foresee Pharmaceuticals, T-Balance Therapeutics, Teva Pharmaceutical, AstraZeneca, Cumberland Pharmaceuticals, Concentrx Pharmaceuticals, Sanofi, Oneness Biotech, Novartis, Keymed Biosciences, Suzhou Connect Biopharmaceuticals, 4D Pharma Plc, Hoffman-La-Roche, Celltrion, Glenmark Pharmaceuticals, Archivel Farma, Siolta Therapeutics, and others. (Albany, USA) […]
Celebrating Courage and Determination, Destiny Over Diagnosis, a 501(c)(3) organization, will host its Third Annual Awards Gala on August 3, 2024. The event will honor ten individuals who have demonstrated resilience and determination in overcoming their diagnoses to live their lives to the fullest. Founded by Sarah Mae in 2020, after her 16-year battle with […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, AL Amyloidosis pipeline constitutes 10+ key companies continuously working towards developing 10+ AL Amyloidosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “AL Amyloidosis Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Mesothelioma pipeline constitutes 45+ key companies continuously working towards developing 50+ Mesothelioma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Mesothelioma Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]
CEO of Jorge 360 Staffing sets a benchmark in the medical staffing industry. Betzabe Wintermute, the CEO of Jorge 360 Staffing, exemplifies the American dream through her journey from a Peruvian immigrant to a prominent business leader. Raised in Peru, Wintermute’s early life was marked by a strong emphasis on education and ambition. Today, she […]
Encephalopathy Pipeline Encephalopathy companies are Xenon Pharmaceuticals, Rebiotix, Axcella Health, Neurocrine Biosciences, Takeda, Praxis Precision Medicines, Stoke Therapeutics, Longboard Pharmaceuticals, Knoop Biosciences, Praxis Precision Medicine, Q-State Biosciences, Inc, Ocera Therapeutics, and others. (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Encephalopathy pipeline constitutes 70+ key companies continuously working towards developing 70+ Encephalopathy treatment […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, HER2-Positive Breast Cancer pipeline constitutes 60+ key companies continuously working towards developing 65+ HER2-Positive Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “HER2-Positive Breast Cancer Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights […]
